Your browser doesn't support javascript.
loading
Prognostic value of MACC1 and proficient mismatch repair status for recurrence risk prediction in stage II colon cancer patients: the BIOGRID studies.
Rohr, U-P; Herrmann, P; Ilm, K; Zhang, H; Lohmann, S; Reiser, A; Muranyi, A; Smith, J; Burock, S; Osterland, M; Leith, K; Singh, S; Brunhoeber, P; Bowermaster, R; Tie, J; Christie, M; Wong, H-L; Waring, P; Shanmugam, K; Gibbs, P; Stein, U.
Afiliación
  • Rohr UP; Divisional Medical and Scientific Affairs, Roche, Basel, Switzerland.
  • Herrmann P; Klinik für Innere Medizin I, Hämatologie, Onkologie und Stammzelltransplantation, University Freiburg, Germany.
  • Ilm K; Translational Oncology of Solid Cancer, Experimental and Clinical Research Center, Charité Universitätsmedizin Berlin.
  • Zhang H; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Lohmann S; Translational Oncology of Solid Cancer, Experimental and Clinical Research Center, Charité Universitätsmedizin Berlin.
  • Reiser A; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Muranyi A; Divisional Biomarker Group, Roche, Basel, Switzerland.
  • Smith J; Roche Diagnostics GmbH, Penzberg, Germany.
  • Burock S; Roche Diagnostics GmbH, Penzberg, Germany.
  • Osterland M; Ventana Medical Systems Inc., Tucson, USA.
  • Leith K; Translational Oncology of Solid Cancer, Experimental and Clinical Research Center, Charité Universitätsmedizin Berlin.
  • Singh S; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Brunhoeber P; Charité Comprehensive Cancer Center, Berlin.
  • Bowermaster R; Translational Oncology of Solid Cancer, Experimental and Clinical Research Center, Charité Universitätsmedizin Berlin.
  • Tie J; Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Christie M; Zuse Institute Berlin, Berlin, Germany.
  • Wong HL; Ventana Medical Systems Inc., Tucson, USA.
  • Waring P; Ventana Medical Systems Inc., Tucson, USA.
  • Shanmugam K; Ventana Medical Systems Inc., Tucson, USA.
  • Gibbs P; Ventana Medical Systems Inc., Tucson, USA.
  • Stein U; Walter and Eliza Hall Institute, Melbourne, Australia.
Ann Oncol ; 28(8): 1869-1875, 2017 Aug 01.
Article en En | MEDLINE | ID: mdl-28460000
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Neoplasias del Colon / Reparación de la Incompatibilidad de ADN / Recurrencia Local de Neoplasia Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Neoplasias del Colon / Reparación de la Incompatibilidad de ADN / Recurrencia Local de Neoplasia Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Suiza